| For: | Horowitz M, Cai L, Islam MS. Glucagon-like-peptide-1 receptor agonists and the management of type 2 diabetes-backwards and forwards. World J Diabetes 2024; 15(3): 326-330 [PMID: 38591090 DOI: 10.4239/wjd.v15.i3.326] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9358/full/v15/i3/326.htm |
| Number | Citing Articles |
| 1 |
Zeyad Elawa, Ahmed Khalil, Ahmed Kardousha, Ahmed ElAwwa, Ashraf T. Soliman. GLP-1 receptor agonists and surgical care: implications for bariatric Procedures, perioperative Outcomes, and nutritional optimization. Diabetes Research and Clinical Practice 2026; 237 doi: 10.1016/j.diabres.2026.113332
|
| 2 |
Simona Di Martino, Maria De Rosa. Peptide-based therapeutics targeting GPCRs: recent applications in the treatment of metabolic disorders. Frontiers in Pharmacology 2026; 17 doi: 10.3389/fphar.2026.1930768
|